Peng L. Xia
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosis.
Journal: Nature communications
Published: November 27, 2025
Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.
Engineered CAR-NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 28, 2025
Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models.
Journal: Cell reports. Medicine
Published: June 04, 2025
Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors.
Journal: Cell reports. Medicine
Published: May 13, 2025
CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models.
Journal: JHEP reports : innovation in hepatology
Published: April 21, 2025
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 08, 2025
Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma.
Journal: Cell death & disease
Published: November 16, 2024
WDR4 drives tumour-associated macrophage reprogramming and tumour progression via selective translation and membrane cholesterol efflux.
Journal: Nature cell biology
Published: November 14, 2024
ADH1C maintains the homeostasis of metabolic microenvironment to inhibit steatotic hepatocellular carcinoma.
Journal: Metabolism: clinical and experimental
Published: October 31, 2024
Quantitative CRACI reveals transcriptome-wide distribution of RNA dihydrouridine at base resolution.
Quantitative CRACI reveals transcriptome-wide distribution of RNA dihydrouridine at base resolution.
Journal: Nature communications
Published: October 24, 2024
CpG-Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2-Mediated Remodeling of Tumor-Associated Macrophages.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 13, 2024
Last Updated: 09/26/2026